388 participants
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2026-01-14
- Completion:
- 2028-03-31
Conditions
- Neovascular Age-Related Macular Degeneration (nAMD)
- Wet AMD
Interventions
- GENETIC
- BIOLOGICAL
No Results Yet